Interstitial lung disease in polymyositis and dermatomyositis

The experience with corticosteroid monotherapy is discouraging but cyclophosphamide, given as daily oral or intravenous pulse therapy together with Corticosteroids, was found to be beneficial in many patients and the weight of the current evidence supports the use of cycloph phosphamide first.